Fig. 5From: DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN responseSchematic showing that DMO-CAP inhibits influenza virus replication. DMO-CAP activated the MAPK pathways, thereby leading to Nrf2 expression and subsequent activation of HO-1 gene expression, as well as the up-regulation HO-1 activities host cellular type I IFN response with induction of ISGs expression, which finally leads to inhibition of influenza virus replicationBack to article page